According to the latest information released by the Fungicide Resistance Action Committee (FRAC), over 30 fungicide selective targets have been identified and acknowledged in the field of fungicide ...

Histamine receptor, a typical G-protein-coupled receptor (GPCR), is important mediator of signalling and is responsible for regulation of human autoimmunity. Here, the authors report an artificial ...

Infectious and non-infectious diseases (autoimmune disorders, cancer, and cardiovascular diseases) caused by bacteria, viruses, and fungi can be identified quickly and accurately with Surface Plasmon ...

Optical biosensors leverage optical signal transduction mechanisms to enhance the sensitivity and specificity of biomarker detection. These sensors employ fluorescence detection, surface plasmon ...

Department of Clinical Microbiology, Umeå University, Umeå 901 87, Sweden Wallenberg Centre for Molecular Medicine (WCMM), Umeå University, Umeå 901 87, Sweden Umeå Centre for Microbial Research (UCMR ...

Producing the best biotherapeutics depends increasingly on the use of sensors to track the process. One way to do that is with Raman spectroscopy. Recently, Ishan Barman, PhD, professor of ...

This strategic advantage has fueled a surge in real estate demand, making SPR an attractive choice for both homebuyers and investors. Thus, both the Dwarka Expressway and the Southern Peripheral ...

Department of Biochemical Science and Technology, National Taiwan University, Taipei 10617, Taiwan Department of Chemistry, National Taiwan University, Taipei 10617, Taiwan Center for Emerging ...

“Incorporating SPR into these workflows has traditionally ... Canadian life sciences tools company specializing in innovative biosensor technology for the academic and biopharmaceutical sectors.

Spirit AeroSystems Holdings, Inc. engages in the design and manufacture of aero structures for commercial and defense aircraft. It operates through the following segments: Commercial, Defense and ...

Roche and Boehringer Ingelheim have both formed partnerships with tech companies this week to develop and deploy wearable biosensor technology for use in clinical trials and patient monitoring.